What You Should Know: - Eko, a cardiopulmonary digital health company launches its next-generation Eko DUO, an FDA-cleared cardiac assessment tool that functions as an electrocardiogram (ECG) and digital stethoscope to detect early signs of heart disease and facilitate timely care and personalized disease management. - DUO is a pocket-sized cardiac examination system for clinicians used to detect early signs of heart disease and facilitate timely care for patients in and out of the clinic.
Read More
Cardiac Monitoring
Ultromics Raises $33M for AI-Enabled Echocardiograms to Help Clinicians Diagnose Heart Disease
What You Should Know: - Today, Ultromics, an Oxford, England-based health-tech startup announced it has raised $33M in Series B funding led by Blue Ventures, the investing arm of Blue Cross Blue Shield, and also includes investment from Optum Ventures, GV, and Oxford Sciences. - Born at the University of Oxford and built-in partnership with the U.K.’s NHS, Ultromics has developed the first fully automated solution for echocardiography and analysis of global longitudinal strain (GLS).
Read More
Medtronic Awarded FDA Clearance for 2 AI Algorithms for Cardiac Monitoring
What You Should Know: - Medtronic announced U.S. Food and Drug Administration (FDA) clearance for two AccuRhythm™ AI algorithms for use with the LINQ II™ insertable cardiac monitor (ICM) – and the presentation of AccuRhythm AI validation data this week at Heart Rhythm 2021. - AccuRhythm AI applies artificial intelligence (AI) to heart rhythm event data collected by LINQ II, improving the accuracy of information physicians receive so they can better diagnose and treat abnormal heart
Read More
Could ‘Hospitals Without Walls’ Be the New Normal for Telehealth and Remote Patient Monitoring?
The statistics surrounding the COVID-19 pandemic continue to be startling, despite the ever-growing mental and physical fatigue that we’ve all experienced living through this frightening, intimidating and unprecedented era. More than 125 million cases worldwide have resulted in a death toll closing in on three million, while in the United States alone, 30 million reported infections have resulted in a death toll that reached 550,000. (1) One thing that can be said for certain about
Read More
The Future of Remote Care Automation Begins with Cardiac Rehabilitation
2020 was undeniably the year that saw telehealth and remote care services come to the forefront of medical care. Many have hypothesized that, in the post-COVID world, remote care programs will be ubiquitous throughout hospitals and health systems. However, such a future is far from certain, as too many organizations currently lack the budget, IT infrastructure, and time necessary to implement new innovative remote care programs. There is a considerable disparity between the hype surrounding
Read More
How Will Philips Acquisition of BioTelemetry Impact The Cardiac Monitoring Market?
At the end of December 2020, Philips announced the planned acquisition of BioTelemetry for $2.8 billion in cash. - BioTelemetry was formed in 2013 after a series of acquisitions from the initial founding company CardioNet, Inc. - CardioNet, Inc. based in San Diego, USA was initially founded in 1994. - After a multitude of acquisitions in recent years, BioTelemetry has established itself as a leading cardiac powerhouse, specializing in mobile and wireless medical technology. After this
Read More
Casana Raises $14M to Expand IoT Heart Health Toilet Seat
What You Should Know: - Casana raises $14M in Series A funding to pursue FDA clearance for its an IoT heart health toilet seat that captures clinically relevant measurements, including heart rate, blood pressure, blood oxygenation, and cardiac output. Casana, previously known as Heart Health Intelligence, Inc., a healthcare technology firm that is re-inventing in-home health monitoring, today announced that it has raised $14M in Series A funding, bringing the total capital raised to
Read More
The Combination of 5G and AI Will Transform Healthcare in 2021
Not many will disagree that the global pandemic has accelerated the use of technology in healthcare. With a healthcare system stressed to a breaking point, medical professionals have had to prioritize critical cases and increasingly turn to technology tools such as telemedicine and remote patient monitoring to manage the needs of their non-COVID patients. As we begin to look beyond the pandemic, we will not only have the lessons of this time but improved tools to support the delivery of
Read More
Boston Scientific Acquires Remote Cardiac Monitoring Company Preventice Solutions for $1.2B
What You Should Know: - Boston Scientific announces an agreement to acquire Preventice Solutions, a leading developer of mobile health solutions and remote monitoring services that connect patients and caregivers for $1.2B. - The acquisition of external cardiac monitoring technologies and services providers will expand Boston Scientific’s rhythm management diagnostics portfolio and capabilities. Boston Scientific today announced that it has acquired Preventice Solutions, Inc., a
Read More
2020’s Top 20 Digital Health M&A Deals Totaled $50B
Teladoc Health and Livongo Merge The combination of Teladoc Health and Livongo creates a global leader in consumer-centered virtual care. The combined company is positioned to execute quantified opportunities to drive revenue synergies of $100 million by the end of the second year following the close, reaching $500 million on a run-rate basis by 2025. Price: $18.5B in value based on each share of Livongo will be exchanged for 0.5920x shares of Teladoc Health plus cash consideration of
Read More
